Literature DB >> 17074897

Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Alessandra Bragonzi1, Lutz Wiehlmann, Jens Klockgether, Nina Cramer, Dieter Worlitzsch, Gerd Döring, Burkhard Tümmler.   

Abstract

The mucA gene of the muc operon, which is instrumental in the control of the biosynthesis of the exopolysaccharide alginate, is a hotspot of mutation in Pseudomonas aeruginosa, a micro-organism that chronically colonizes the airways of individuals with cystic fibrosis (CF). The mucA, mucB and mucD genes were sequenced in nine environmental isolates from aquatic habitats, and in 37 P. aeruginosa strains isolated from 10 patients with CF, at onset or at a late stage of chronic airway colonization, in order to elucidate whether there was any association between mutation and background genotype. The 61 identified single nucleotide polymorphisms (SNPs) segregated into 18 mucABD genotypes. Acquired and de novo stop mucA mutations were present in 14 isolates (38 %) of five mucABD genotypes. DeltaG430 was the most frequent and recurrent mucA mutation detected in four genotypes. The classification of strains by mucABD genotype was generally concordant with that by genome-wide SpeI fragment pattern or multilocus SNP genotypes. The exceptions point to intragenic mosaicism and interclonal recombination as major forces for intraclonal evolution at the mucABD locus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074897     DOI: 10.1099/mic.0.29175-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  47 in total

Review 1.  Making the cut: central roles of intramembrane proteolysis in pathogenic microorganisms.

Authors:  Sinisa Urban
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

2.  Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.

Authors:  M Codagnone; E Cianci; A Lamolinara; V C Mari; A Nespoli; E Isopi; D Mattoscio; M Arita; A Bragonzi; M Iezzi; M Romano; A Recchiuti
Journal:  Mucosal Immunol       Date:  2017-04-19       Impact factor: 7.313

3.  Diversity of the abundant pKLC102/PAGI-2 family of genomic islands in Pseudomonas aeruginosa.

Authors:  Jens Klockgether; Dieco Würdemann; Oleg Reva; Lutz Wiehlmann; Burkhard Tümmler
Journal:  J Bacteriol       Date:  2006-12-28       Impact factor: 3.490

4.  Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  J Cyst Fibros       Date:  2019-04-26       Impact factor: 5.482

Review 5.  Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface.

Authors:  Sankalp Malhotra; Don Hayes; Daniel J Wozniak
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

6.  Developing an international Pseudomonas aeruginosa reference panel.

Authors:  Anthony De Soyza; Amanda J Hall; Eshwar Mahenthiralingam; Pavel Drevinek; Wieslaw Kaca; Zuzanna Drulis-Kawa; Stoyanka R Stoitsova; Veronika Toth; Tom Coenye; James E A Zlosnik; Jane L Burns; Isabel Sá-Correia; Daniel De Vos; Jean-Paul Pirnay; Timothy J Kidd; David Reid; Jim Manos; Jens Klockgether; Lutz Wiehlmann; Burkhard Tümmler; Siobhán McClean; Craig Winstanley
Journal:  Microbiologyopen       Date:  2013-11-11       Impact factor: 3.139

7.  Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli.

Authors:  Dagmara I Kisiela; Matthew Radey; Sandip Paul; Stephen Porter; Kseniya Polukhina; Veronika Tchesnokova; Sofiya Shevchenko; Diana Chan; Maliha Aziz; Timothy J Johnson; Lance B Price; James R Johnson; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2017-06-13       Impact factor: 3.490

8.  Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa.

Authors:  Alejandro J Moyano; Andrea M Smania
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

9.  Pseudomonas aeruginosa Alginate Benefits Staphylococcus aureus?

Authors:  Michael J Schurr
Journal:  J Bacteriol       Date:  2020-03-26       Impact factor: 3.490

10.  Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.

Authors:  Cristina Cigana; Laura Curcurù; Maria Rosaria Leone; Teresa Ieranò; Nicola Ivan Lorè; Irene Bianconi; Alba Silipo; Flora Cozzolino; Rosa Lanzetta; Antonio Molinaro; Maria Lina Bernardini; Alessandra Bragonzi
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.